Bcl-2-associated death promoter

Jump to: navigation, search


BCL2-antagonist of cell death
Identifiers
Symbol(s) BAD; BBC2; BCL2L8
External IDs OMIM: 603167 MGI1096330 Homologene3189
RNA expression pattern

PBB GE BAD 1861 at tn.png

PBB GE BAD 209364 at tn.png

More reference expression data

Orthologs
Human Mouse
Entrez 572 12015
Ensembl ENSG00000002330 ENSMUSG00000024959
Uniprot Q92934 Q3TFU7
Refseq NM_004322 (mRNA)
NP_004313 (protein)
NM_007522 (mRNA)
NP_031548 (protein)
Location Chr 11: 63.79 - 63.81 Mb Chr 19: 7.01 - 7.02 Mb
Pubmed search [1] [2]

The Bcl-2-associated death promoter (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family which is involved in initiating apoptosis. It does not contain a C-terminal transmembrane domain for outer mitochondrial membrane and nuclear envelope targeting, unlike most other members of the Bcl-2 family [1]. Pro-apoptotic activation of this protein occurs through phosphorylation[2]. After activation, it is able to form a heterodimer with anti-apoptotic proteins and prevent them from stopping apoptosis.

BAD is a member of the BH3-only family [3], a subfamily of the Bcl-2 family.

The Bcl-2-associated death promoter (BAD) protein is a member of the Bcl-2 gene family. Some members of this family are pro-apoptotic (e.g., Bax, Bak) while others are anti-apoptotic (e.g., Bcl-2, Bcl-xL). Bax/Bak are believed to initiate apoptosis by forming a pore in the mitochondrial outer membrane that allows cytochrome c to escape into the cytoplasm and activate the pro-apoptotic caspase cascade. The anti-apoptotic Bcl proteins inhibit cytochrome c release through the mitochondrial pore and also inhibit activation of the cytoplasmic caspase cascade by cytochrome c.[4]

BAD does not contain a C-terminal transmembrane domain for outer mitochondrial membrane and nuclear envelope targeting, unlike most other members of the Bcl-2 family [1]. BAD is a member of the BH3-only family [3], a subfamily of the Bcl-2 family.

Dephosphorylated BAD forms a heterodimer with Bcl-2 and Bcl-xL, inactivating them and thus allowing Bax/Bak-triggered apoptosis. On the other hand, BAD phosphorylation by Akt/protein kinase B (triggered by PIP3), causes formation of the BAD-(14-3-3)protein heterodimer. This leaves Bcl-2 free to inhibit Bax-triggered apoptosis.[5] BAD phosphorylation is thus anti-apoptotic, and BAD dephosphorylation (e.g., by Ca++-stimulated Calcineurin) is pro-apoptotic. The latter may be involved in neural diseases such as schizophrenia.[6]

See also

References

  1. Sheau Yu Hsu, et al. (1997). "Interference of BAD (Bcl-xL/Bcl-2-Associated Death Promoter)-Induced Apoptosis in Mammalian Cells by 14–3-3 Isoforms and P11". Molecular Endocrinology 11 (12).
  2. Entrez Gene entry for BAD. NCBI. Retrieved on [[2006-12-19]].
  3. Adachi M. and Imai K. (2002). "The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2". Cell death and differentiation 9 (11).
  4. Helmreich, E.J.M. (2001) The Biochemistry of Cell Signalling, pp. 238-43
  5. E.J.M. (2001) The Biochemistry of Cell Signalling, pp. 242
  6. Foster, T.C. et al (2001) J. Neurosci. 21, 4066-4073, "Calcineurin Links Ca++ Dysregulation with Brain Aging"(

Further reading

  • Tolstrup M, Ostergaard L, Laursen AL, et al. (2004). "HIV/SIV escape from immune surveillance: focus on Nef.". Curr. HIV Res. 2 (2): 141-51. PMID 15078178.
  • Jiang P, Du W, Wu M (2007). "p53 and Bad: remote strangers become close friends.". Cell Res. 17 (4): 283-5. doi:10.1038/cr.2007.19. PMID 17404594.
  • Yang E, Zha J, Jockel J, et al. (1995). "Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.". Cell 80 (2): 285-91. PMID 7834748.
  • Zha J, Harada H, Yang E, et al. (1997). "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)". Cell 87 (4): 619-28. PMID 8929531.
  • Wang HG, Rapp UR, Reed JC (1997). "Bcl-2 targets the protein kinase Raf-1 to mitochondria.". Cell 87 (4): 629-38. PMID 8929532.
  • Inohara N, Ding L, Chen S, Núñez G (1997). "harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).". EMBO J. 16 (7): 1686-94. doi:10.1093/emboj/16.7.1686. PMID 9130713.
  • Zha J, Harada H, Osipov K, et al. (1997). "BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.". J. Biol. Chem. 272 (39): 24101-4. PMID 9305851.
  • Hsu SY, Kaipia A, Zhu L, Hsueh AJ (1997). "Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11.". Mol. Endocrinol. 11 (12): 1858-67. PMID 9369453.
  • del Peso L, González-García M, Page C, et al. (1997). "Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.". Science 278 (5338): 687-9. PMID 9381178.
  • Ottilie S, Diaz JL, Horne W, et al. (1998). "Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.". J. Biol. Chem. 272 (49): 30866-72. PMID 9388232.
  • Huang DC, Adams JM, Cory S (1998). "The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.". EMBO J. 17 (4): 1029-39. doi:10.1093/emboj/17.4.1029. PMID 9463381.
  • Blume-Jensen P, Janknecht R, Hunter T (1998). "The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136.". Curr. Biol. 8 (13): 779-82. PMID 9651683.
  • Strobel T, Tai YT, Korsmeyer S, Cannistra SA (1998). "BAD partly reverses paclitaxel resistance in human ovarian cancer cells.". Oncogene 17 (19): 2419-27. doi:10.1038/sj.onc.1202180. PMID 9824152.
  • Song Q, Kuang Y, Dixit VM, Vincenz C (1999). "Boo, a novel negative regulator of cell death, interacts with Apaf-1.". EMBO J. 18 (1): 167-78. doi:10.1093/emboj/18.1.167. PMID 9878060.
  • Yasuda M, Han JW, Dionne CA, et al. (1999). "BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3.". Cancer Res. 59 (3): 533-7. PMID 9973195.
  • Wang HG, Pathan N, Ethell IM, et al. (1999). "Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.". Science 284 (5412): 339-43. PMID 10195903.
  • Holmgreen SP, Huang DC, Adams JM, Cory S (1999). "Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members.". Cell Death Differ. 6 (6): 525-32. doi:10.1038/sj.cdd.4400519. PMID 10381646.
  • Ostrerova N, Petrucelli L, Farrer M, et al. (1999). "alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.". J. Neurosci. 19 (14): 5782-91. PMID 10407019.
  • Scheid MP, Schubert KM, Duronio V (1999). "Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase.". J. Biol. Chem. 274 (43): 31108-13. PMID 10521512.
  • Bonni A, Brunet A, West AE, et al. (1999). "Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.". Science 286 (5443): 1358-62. PMID 10558990.


External links

de:Bcl-2-Antagonist-of-Cell-Death


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox